SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Alan Cole who wrote (1791)2/19/1999 11:05:00 PM
From: John Metcalf  Read Replies (1) of 10280
 
It's a fascinating question in regard to how selective serotonin reuptake inhibitors compare to each other. There are multiple serotonin receptors, and multiple dopamine receptors, in the 5HT receptor group, which are affected by drugs of this class.

It seems obvious that selectivity is important. These drugs are prescribed by psychiatrists, based on subjective impressions of affect and behavior.

Sepracor has only claimed the advantages that ICE-Prozac has a shorter washout period and less sexual dysfunction in males. This is important because anti-depressants are prescribed subjectively.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News